Patent ID: 9662310
Date: 2017-05-30
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method of treating a disease caused by inhibition of fibrinolysis comprising administering a compound of formula (I): or a pharmacologically acceptable salt thereof, to a subject, wherein: R R R R substituent group A consists of a hydroxy group, a halogeno group, a cyano group, a nitro group, an amino group, a carboxy group, a C1 to C3 alkyl group, a halogeno-C1 to C3 alkyl group, a C3 to C8 cycloalkyl group, a C1 to C3 alkoxy group, a halogeno-C1 to C3 alkoxy group, a C1 to C3 alkylsulfonyl group, an aryl group, a saturated heterocyclyl group, an unsaturated heterocyclyl group, and an aryloxy group.